Lauren Santye, Assistant Editor

Idelvion is the first and only factor IX therapy that gives high level protection for up to 14-day dosing for hemophilia B.

Naloxone helps combat heroin and prescription drug epidemic.

Approximately 2.3 million people worldwide are infected with both HIV and hepatitis C virus.

Green tea loses its potential in IBD as an antioxidant after a meal rich in iron.

Researchers evaluate the link between vitamin D and multiple sclerosis development.

Shoppable services allow consumers to use pricing information to comparison shop for healthcare services and providers.

The day-to-day struggle of a mom dealing with the symptoms of multiple sclerosis.

Keytruda found to improve overall survival compared with chemotherapy in patients with non-small cell lung cancer.

Keytruda showed an improvement in overall survival compared with chemotherapy in patients with NSCLC.

Humana announces exclusive or preferred access to Praluent for Medicare and commercial patients.

Announcement increases access for Praluent to formularies that cover in excess of 170 million lives across the United States.

Drug that treats GNE myopathy (GNEM) causes improved muscle strength in upper extremities.

New method examines the genetic background of tumors for more effective prostate cancer therapy.

Researchers compare prescription refill records among patients who refill medications via mail order and traditional pharmacy.

New formulation of Isentress shows similar efficacy to currently available twice-daily formulation for the HIV therapy.

New once-daily formulation of Isentress shows similar efficacy to the currently approved twice-daily formulation of the HIV treatment.

Treatment shows promise in fighting lymphoma in early studies.

The use of Adderall without a prescription found to dramatically increase.

New analysis provides faster tests and lower costs for women with estrogen positive-receptor (ER-positive) breast cancer.

Discovery may lead to significant new HIV treatments.

Most read articles of the week on The American Journal of Pharmacy Benefits.

ONC201 caused p53-independent cell death and cell cycle arrest in lymphoma and acute leukemia patient samples.

Despite progress in legalizing medical marijuana, incorporating it into clinical trials for epilepsy to prevent seizures remains difficult.

Ibrutinib (Imbruvica) is the first FDA-approved chemotherapy-free treatment for patients with chronic lymphocytic leukemia (CLL).

Ibrutinib (Imbruvica) is the first chemotherapy-free treatment for first line CLL patients approved by the FDA.

Cost increases hits hard as average annual prescription drug cost is three-quarters of the average social security retirement benefit.

Study found no standalone Medicare Part D plans covered vaccinations without out-of-pocket payments.

Abraxane treats patients with advanced, squamous non-small cell lung cancer (NSCLC).

Ocrelizumab shows promise reducing symptoms of MS.

Ocrelizumab selectively targets CD20+B cells to reduce disease activity in patients with primary progressive multiple sclerosis.